Bruker Corporation applications

DART enables near effortless inspection of tablets, powder, and liquid formulations.  Qualitative and quantitative analysis are completed by using commercially available LC/MS systems from all of the major mass spectrometry vendors.  Rapid reaction monitoring is facilitated with the development of our Mobile DART-Acquity QDa platform which can move from laboratory to pilot plant in minutes enabling generation of high quality information in seconds to improve your decision making process.

Lead molecules against any target. At record pace. Target to lead molecule in weeks, not months. The Opto™ Plasma B Discovery workflow on the automated Beacon® system enables high-resolution screening of plasma B cells with unprecedented speed.

The new standard for quality, capacity, and speed. Deliver the best cell lines. Set your IND up for success by getting FDA-accepted monoclonality assurance in just days.

Deliver the right cells to the patient on time. Maximize Functional Characterization of Your Precious T Cell Samples. The Opto™ Cell Therapy Development workflow accelerates the creation of better therapeutics by performing multiple functional assays across 1,000s of individual T cells in a matter of days. Deeply characterize, profile, and map your T cell populations at the single-cell level to directly link phenotype to gene expression.

We Provide the Fastest Path to Production Ready Organisms In Synthetic Biology. Accelerate the Design-Build-Test Process. Testing used to take months. Our platform makes it happen in hours to days. Let your design and build team go. We’ve got test covered.